How and When to Consider Genetic Testing for Colon Cancer?

Gastroenterology. 2018 Oct;155(4):955-959. doi: 10.1053/j.gastro.2018.08.031. Epub 2018 Aug 24.

Authors

Veroushka Ballester¹, Marcia Cruz-Correa²

Affiliations

¹ Department of Medicine, Division of Digestive and Liver Diseases, Columbia University Medical Center, New York, New York.
² Departments of Medicine, Biochemistry and Surgery, University of Puerto Rico Medical Sciences Campus, San Juan, Puerto Rico; Division of Cancer Biology, University of Puerto Rico Comprehensive Cancer Center, San Juan, Puerto Rico. Electronic address: Marcia.cruz1@upr.edu.

PMID: 30148981
DOI: 10.1053/j.gastro.2018.08.031

No abstract available

MeSH terms

Biomarkers, Tumor / genetics*
Clinical Decision-Making
Colorectal Neoplasms, Hereditary Nonpolyposis / diagnosis*
Colorectal Neoplasms, Hereditary Nonpolyposis / economics
Colorectal Neoplasms, Hereditary Nonpolyposis / genetics*
Colorectal Neoplasms, Hereditary Nonpolyposis / pathology
Genetic Predisposition to Disease
Genetic Testing / economics
Genetic Testing / methods*
Health Care Costs
Heredity
Humans
Patient Selection
Pedigree
Predictive Value of Tests
Prognosis
Risk Assessment
Risk Factors

Substances

Biomarkers, Tumor